Pd. Thompson et al., Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts, J MOL ENDOC, 27(2), 2001, pp. 211-227
The vitamin D receptor (VDR) stimulates transcription as a 1,25-dihydroxyvi
tamin D-3 (1,25(OH)(2)D-3)-activated heterodimer with retinoid X receptor (
RXR). RXR also forms homodimers to mediate 9-cis retinoic acid (9-cis RA)-i
nduced gene expression. Both receptors possess a C-terminal hormone-depende
nt activation function-2 (AF-2), a highly conserved region that binds coact
ivators to transduce the transcriptional signal. By replacing single amino
acids within the AF-2 of human RXR alpha (hRXR alpha) or mouse RXR beta (mR
XR beta), the contribution of these residues to transactivation by the RXR-
VDR heterodimer and the RXR-RXR homodimer was evaluated. In 9-cis RA-respon
sive homodimers, the second and fourth positions of the AF-2 (leucine and g
lutamate respectively) are essential. However, in the context of an RXR-VDR
heterodimer activated by 1,25(OH)(2)D-3, alteration of these two RXR resid
ues has little effect. Instead, AF-2 residues located towards the C-terminu
s, such as the penultimate position (L455 in hRXR alpha or L441 in mRXR bet
a), are crucial for RXR-VDR heterodimers. Indeed, L455A mutant RXR exerts a
dominant negative effect on RXR-VDR transcriptional responsiveness to 1,25
(OH)(2)D-3. Further experiments with a mutant hRXR alpha (F313A) which elic
its 9-cis RA-independent transactivation as a homodimer demonstrate that wh
en heterodimerized with VDR, this RXR mutant is incapable of activating the
RXR-VDR heterocomplex in the absence of the VDR ligand. Taken together, th
ese results indicate that RXR is a subordinate, yet essential transcription
al partner in RXR-VDR-mediated activation of gene expression. Furthermore,
a functional switch in RXR AF-2 signaling occurs between RXR residues in th
e homodimeric versus the heterodimeric states, likely reflecting different
interactions between subregions of the AF-2 and coactivator(s).